Distribution of plasma folate forms in hemodialysis patients receiving high daily doses of l-folinic or folic acid
- 1 December 2002
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 62 (6) , 2246-2249
- https://doi.org/10.1046/j.1523-1755.2002.00666.x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Homocysteine-lowering treatment: an overviewExpert Opinion on Pharmacotherapy, 2001
- L-folinic acid versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patientsKidney International, 2001
- Hyperhomocysteinemia in hemodialysis patients: Effects of 12-month supplementation with hydrosoluble vitaminsKidney International, 2000
- Controlled Comparison of l -5-Methyltetrahydrofolate Versus Folic Acid for the Treatment of Hyperhomocysteinemia in Hemodialysis PatientsCirculation, 2000
- Reversal of hyperhomocyst(e)inaemia in chronic renal failure—is folic or folinic acid the answer?Nephrology Dialysis Transplantation, 1999
- Effective correction of hyperhomocysteinemia in hemodialysis patients by intravenous folinic acid and pyridoxine therapyKidney International, 1999
- High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patientsKidney International, 1996
- Net uptake of plasma homocysteine by the rat kidney in vivoAtherosclerosis, 1995
- Plasma folate conjugase activities and folate concentrations in patients receiving hemodialysisThe Journal of Nutritional Biochemistry, 1994
- Disposition of folic acid and its metabolites: A comparison with leucovorinClinical Pharmacology & Therapeutics, 1994